Joshua (Josh) Resnick, MD
Partner·RA Capital Management
Bio
Professional summary
Josh Resnick is a Partner at RA Capital Management, where his official profile says he leads early-stage private investments and oversees the creation of new companies developing drugs, medical devices, diagnostics, and research tools. He has more than 15 years of experience across investing, company formation, company leadership, and drug development stages from discovery through commercialization. Before RA Capital, he was co-lead of SV Health Investors’ US Biotech practice, President and Managing Partner at MRL Ventures Fund, a Venture Partner at Atlas Venture, and a Partner at Prism Venture Partners. He is also listed as a Harvard Medical School faculty member and an attending physician in Emergency Medicine at Massachusetts General Hospital. He holds a BA in Chemistry from Williams College, an MD from the University of Pennsylvania School of Medicine, and an MBA from Wharton.
Investment focus
Stage, sector, and overall fit
Stage
Sector
Thesis
Notable companies
Selected portfolio companies the partner has backed
How to approach
Framing and angles for outreach
Pitch framing
Strong fit for founder outreach around early-stage healthcare company creation, especially therapeutics or platform ideas needing venture-building support.
Partneralization hooks
- 1Reference his hands-on company formation background across SV Health Investors, MRL Ventures, Atlas Venture, and Prism.
- 2For clinically relevant products, mention his continued emergency medicine and Harvard Medical School connection.
Background
Career, education, and skills
Career history
- RA Capital ManagementPartner2018–present
- Raven (RA Capital Incubator)Co-Founder & Presidentongoing
- Massachusetts General HospitalAttending Physician, Emergency Medicine2015–present
- Synolo TherapeuticsCo-Founder
- Stylus MedicineCo-Founder
Education
- University of Pennsylvania, Perelman School of MedicineMD2002
- The Wharton School, University of PennsylvaniaMBA2002
Skills
Other partners at RA Capital Management
12 more profiles
Abigail (Lauterbach) Schmitz
Senior Associate
RA Capital Management
TechAtlas senior associate evaluating biotech opportunities and competitive landscapes.
Adam Prince, MD
Senior Associate, Strategic Initiatives
RA Capital Management
RA Capital TechAtlas senior associate with cardiology and medical training.
Alana MacDonald, Ph.D.
Senior Associate
RA Capital Management
Senior TechAtlas associate focused on biotech diligence, landscapes, and portfolio strategy.
Alejandro Sevilla
Associate
RA Capital Management
Planetary Health associate focused on climate-tech landscapes and investment evaluation.
Alex Miller
Senior Associate, Venture
RA Capital Management
Venture senior associate focused on biotech diligence and portfolio strategy.
Alex T. Zhang
Vice President, Structured Capital
RA Capital Management
Structured Capital VP focused on healthcare and life-sciences credit investments.
Alexander Martinez-Forte
Director, Quantitative Research & Strategy
RA Capital Management
RA Capital director leading quantitative analyses for investment decisions and portfolio management.
Allison Harrigan
Senior Director Corporate Development
RA Capital Management
Raven corporate development leader focused on biotech company creation.
Alyssa Larson
Director, Healthcare Specialist - Investor Relations
RA Capital Management
TechAtlas director supporting healthcare diligence and investor relations.
Ami Thakrar, PhD
Associate
RA Capital Management
TechAtlas associate focused on biotech diligence and program strategy.
Anish K. More
Vice President, Corporate Development
RA Capital Management
Raven corporate-development VP focused on investment evaluation and NewCo creation.
Anurag Kondapalli
Principal
RA Capital Management
Principal investing across public and private healthcare technology and services companies.